Microbiologics in the Workplace

April 1, 2000
The indoor environment presents a complex challenge when trying to determine the role of fungi and other organisms in causing workplace disease.

Occupational health has been focused on chemical, physical agent and even biomechanical (ergonomics) exposures. Researchers have tried to identify the chemical culprits for diseases and symptoms in a wide spectrum of workplace settings. The failure to identify specific chemicals at levels capable of causing disease in office buildings caused clinicians and scientists to explore other issues such as humidity, temperature and organizational and individual psychosocial factors.

More recently, exposure to microbiological agents has taken center stage in the indoor air quality (IAQ) arena. Fungi, which include molds, bacteria, and viruses, increasingly are being studied as potential culprits for the myriad symptoms which have been reported by inhabitants of sick buildings. A number of workers' compensation and third-party lawsuits have arisen over whether exposure to these small living things produces not just annoying symptoms, but far more serious illnesses, some of which are potentially fatal.

Historical evidence of microbiologic-related disease from molds dates back to the Plague of Athens in 430 B.C. In 1960, approximately 100,000 turkeys died from a toxin produced by the commonly found mold, Aspergillus.

One of the most notorious incidents which helped to drive recent interest occurred in 1976, when a mysterious disease broke out at an American Legion convention in Philadelphia. It was subsequently named Legionnaires' disease.

Since then, IAQ concern has centered around molds, the toxins they produce and specific bacteria such as Legionella pneumophila, the gram-negative bacteria responsible for Legionnaires' disease.

Mixed Environment

Microbiologically, the indoor environment reflects contaminants from the outside as well as building-specific agents. Pollens from trees, grasses and other plants, insects fragments and excreta are known producers of allergies and asthma and are brought inside buildings through doors, HVAC systems and general infiltration. The indoor environment contains dust mites and the potential for animal danders, food and vegetative debris. Housekeeping will impact the exposure potential for many of these agents.

There are a wide variety of molds found in both outdoor and indoor environments. Typically the outdoor levels will exceed that found indoors. As might be expected, the levels of molds will vary by geographic location and weather, e.g., higher with periods of rain. Species of various molds frequently identified in the outdoors, homes and buildings include those of Penicillium, Cladosporium and Aspergillus. However, the relative amounts of each fungi species in the outdoor air versus the indoor are not frequently found to be the same.

Legionella and various fungal species will grow substantially under the right conditions, i.e., nutrient source and water. Legionella frequently is found in water supplies, but also hot tubs and even aerosols from industrial applications. Most of us are familiar with the smell of mold and mildew in damp basements. Molds will grow in humid environments, especially where standing water exists such as flat roofs, damp filters or condensate collection trays. Water damage from leaking roofs or pipes may provide growth opportunities for various fungal species.

The growth rates and extent of growth is related to the temperature as well as factors such as humidity and nutrient availability.

Health Effects

In addition to Legionnaires' disease, various types of microbiologics may produce health problems ranging from the common cold passed from worker to worker to allergies, asthma and humidifier lung (hypersensitivity pneumonitis).

The presence of Stachybotrys species such as S. atra and S. chartarum have created concern due to the disease that has been associated with extensive exposure to these molds and the toxins they and other molds produce, known as mycotoxins. Probably the most recognized mycotoxin is aflatoxin, a known carcinogen produced by Aspergillus species.

The reported health effects of mycotoxicosis include:

  • Immunosuppression
  • Dermatotoxicity
  • Myelosuppression
  • Estrogenicity
  • Hepatoxicity
  • Mutagenicity
  • Nephrotoxicity
  • Teratogenicity
  • Neurotoxicity
  • Carcinogenicity

While such effects have been associated with mycotoxin exposure, the strength of the associations, occurrence in human populations, quality of the studies and applicability to airborne workplace exposures remain to be clarified. Various commodities such as tobacco, meats, spices, seeds, nuts, cereals and grains, milk and dairy products and fruit and vegetables have been shown to contain mycotoxins demonstrating their ubiquity within the environment.

Various molds and their toxins have been implicated in both sick building syndrome (SBS) and specific building-related illnesses (BRI). Studies of symptoms and complaints in what have been identified as "sick" buildings frequently identify cold and flu symptoms, sore throats, mucus membrane irritation, headaches, diarrhea and fatigue.

Attempts to relate these complaints to fungal airborne exposures have run into a variety of problems. These consist of lack of specific illness association, inability to demonstrate differences in exposure between controls and study subjects, and study design. Many studies are in fact case reports or case series, or cross-sectional studies. Cross-sectional studies severely limit the ability to draw causal conclusions.

True stachybortryotoxicosis, first associated with the ingestion of highly contaminated foodstuffs, especially in Russia, has been described as a severe disorder occurring over several weeks. The clinical picture has been reported as being similar to radiation poisoning:

  • Bone marrow effects
  • Fever
  • Nausea/vomiting
  • Leukopenia (low white cell count)
  • Diarrhea
  • Bleeding
  • Abdominal pain
  • Sepsis

The toxicity has been related to a stachybotrys mycotoxin such as trichothecenes. The disorder starts with 3 to 9 days of nausea, vomiting, mucous membrane and skin irritation, abdominal pain, headache and generalized weakness. At 10-14 days, the patient may feel better but bone marrow damage evidenced by luekopenia, anemia, and thrombocytopenia may be found. Depending on the severity of disorder, at 3-4 weeks, coagulation difficulties, bone marrow failure, infection and sepsis are reported. After four weeks, an increased white blood cell count will accompany recovery.

In the early 1990s, Centers for Disease Control investigators reported a cluster of 10 infants from Cleveland, Ohio with acute idiopathic pulmonary hemorrhage, also termed pulmonary hemosiderosis. One infant died. The potential role of Stachybotrys was evaluated. An initial association was later felt to be unfounded as the statistical association was potentially inflated, and there were sampling technique and other concerns.

The annual number of Legionnaires' disease cases, on the other hand, is probably not fully appreciated. It is estimated that 10,000-25,000 cases occur in the United States each year. The bacteria survives principally in water, but to a lesser extent in soil. One study found that 64 percent of a hospital's water supply was contaminated with L. pneumophilia and that 14 percent of the hospital-acquired pneumonias was found to be a Legionella infection. Legionnaires' has been traced to drinking water, bathing, whirlpools, hot tubs, and cleaning medication nebulizers. In immunocompromised individuals, the elderly and persons with underlying diseases such as cancer the attack rate is much greater than in the general population.

One hypothesis for SBS symptoms concerns the role of microbiologic "off-gassing" in the production of sensory irritation. Specifically, certain microbial volatile organic compounds (MVOCs) which include alcohols, terpenes, ketones, esters, aromatic compounds, amines, sulfur-containing compounds and possibly aldehydes are produced during active microorganism growth. MVOCs are occasionally released into the air but at very low concentrations. A 1999 study by Koppi et al studied sensory irritation in mice but failed to show a substantial association with exposure to MVOCs.

Until the precise role of various workplace microbiologic agents in the production of SBS symptoms and specific building-related illness is clearly elucidated, occupational health and safety professionals need to use good judgment in addressing complaints and investigating specific diagnosed conditions. Individuals with allergic rhinitis and asthma will need to be evaluated for both causative agents and exposures to symptom triggers.

It is important to remember that the most common indoor producers and aggravators of these conditions include dust, dust mites, molds and possible cockroach fragments and excreta. Inspection, periodic maintenance and appropriate remediation of water leaks, humid environments and dirt/dust/contamination may help to reduce complaints from building occupants and hopefully have an impact on the risk of building-related illnesses as well.

Contributing Editor Howard M. Sandler, M.D., has more than 25 years in occupational and environmental health. He has served as a medical officer for NIOSH. He has consulted extensively with EPA, OSHA, NIOSH and the Consumer Products Safety Commission. He can be reached via e-mail at [email protected].

Sponsored Recommendations

ISO 45001: Occupational Health and Safety Management Systems (OHSMS)

March 28, 2024
ISO 45001 certification – reduce your organizational risk and promote occupational health and safety (OHS) by working with SGS to achieve certification or migrate to the new standard...

Want to Verify your GHG Emissions Inventory?

March 28, 2024
With the increased focus on climate change, measuring your organization’s carbon footprint is an important first action step. Our Green House Gas (GHG) verification services provide...

Download Free ESG White Paper

March 28, 2024
The Rise and Challenges of ESG – Your Journey to Enhanced Sustainability, Brand and Investor Potential

Free Webinar: Mining & ESG: The Sustainability Mandate

March 28, 2024
Participants in this webinar will understand the business drivers and challenges of ESG and sustainability performance, the 5 steps of the ESG and sustainability cycle, and prioritized...

Voice your opinion!

To join the conversation, and become an exclusive member of EHS Today, create an account today!